诊断 打印 Peritoneal carcinomatosis often spreads across the abdominal lining without forming distinct masses. Because of this, doctors usually need to combine imaging, fluid tests, and sometimes surgery, to confirm a diagnosis. Tests Imaging tests. Imaging tests such as CT, MRI and PET scans are typically the first step in looking for suspected peritoneal carcinomatosis. These scans help identify visible tumor spread, fluid buildup or organ involvement. However, imaging is often not sensitive enough to detect smaller cancers or early peritoneal disease. Therefore, a negative scan does not rule out peritoneal carcinomatosis. Peritoneal washing cytology. In this test, fluid from the abdominal cavity is surgically collected during a minor procedure. It's then examined under a microscope. Healthcare professionals use peritoneal washing cytology to check for cancer cells floating in the peritoneal fluid. Even when no visible cancer is present, a positive cytology result is a strong sign that peritoneal spread has happened. Staging laparoscopy. Staging laparoscopy is a safe, minimally invasive surgical procedure used to look directly inside the abdominal cavity using a small camera. It allows healthcare professionals to inspect the peritoneum, find hidden tumors, and take tissue or fluid samples. This test is especially valuable for finding peritoneal metastases that are too small to be seen with imaging. Tumor marker tests. Tumor marker tests use a sample of blood to look for chemicals made by cancer cells. Circulating tumor DNA (ctDNA). This is a newer blood test that looks for small pieces of DNA from cancer cells in the blood. It can help find peritoneal cancer that doesn't show up on scans. However, the role of ctDNA in diagnosis is still uncertain. 申请预约 诊断与治疗 July 03, 2025 打印 Share on: FacebookTwitterWeChatWeChatCloseWeibo 显示参考文献 Gastric cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1434. Accessed May 13, 2025. National Cancer Institute. Peritoneal carcinomatosis. NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peritoneal-carcinomatosis. Accessed May 13, 2025. Cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ipg688. Accessed May 13, 2025. DeVita VT Jr, et al., eds. Peritoneal metastases and peritoneal mesothelioma. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. ProQuest Ebook Central. Wolters Kluwer; 2023. Accessed May 13, 2025. Lewis KA, et al. Educational review: Updates on therapeutic strategies for gastric cancer with peritoneal metastasis. Annals of Surgical Oncology. 2025; doi:10.1245/s10434-025-17069-3. Sigler GI, et al. Diagnostic advances and novel therapeutics in peritoneal metastasis. Surgical Oncology Clinics of North America. 2025; doi:10.1016/j.soc.2024.12.005. Blaj S, et al. Peritoneal carcinomatosis in colorectal cancer: Review and update of current clinical data. Clinical Colorectal Cancer. 2024; doi:10.1016/j.clcc.2024.05.007. Acs M, et al. Peritoneal metastatic gastric cancer: Local treatment options and recommendations. Current Oncology. 2024; doi:10.3390/curroncol31030109. Foster JM, et al. The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future. CA: A Cancer Journal for Clinicians. 2023; doi:10.3322/caac.21749. Werba G, et al. Treatment and management of peritoneal spread from colorectal cancer peritoneal metastasis. Surgical Oncology Clinics of North America. 2025; doi:10.1016/j.soc.2024.11.001. Pozzar RA, et al. Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers. Gynecology Oncology. 2024; doi:10.1016/j.ygyno.2023.12.013. Huang B, et al. Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery. Annals of Gastroenterological Surgery. 2021; doi:10.1002/ags3.12565. Li Z, et al. Predicting peritoneal carcinomatosis of gastric cancer: A simple model to exempt low-risk patients from unnecessary staging laparoscopy. Frontiers in Surgery. 2022; doi:10.3389/fsurg.2022.916001. Goldman L, et al., eds. Inflammatory and anatomic diseases of the intestine, peritoneum, mesentery, and omentum. In: Goldman-Cecil Medicine. 27th ed. Elsevier; 2024. https://www.clinicalkey.com. Accessed June 13, 2025. Vallejo JS, et al. Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Revista do Colégio Brasileiro de Cirurgiões. 2023; doi:10.1590/0100-6991e-20233421-en. Harris KM. Allscripts EPSi. Mayo Clinic. June 12, 2025. Ferri FF. Ascites. In: Ferri's Clinical Advisor 2025. Elsevier; 2025. https://www.clinicalkey.com. Accessed June 13, 2025. Hoskins MA, et al. Data-driven surveillance protocol for patients at risk for peritoneal recurrence of primary colon cancer: Surveillance for peritoneal carcinomatosis. Journal of Clinical Medicine. 2024; doi:10.3390/jcm13082358. Zhang Y, et al. Risk factors for synchronous peritoneal metastases in colorectal cancer: A systematic review and meta-analysis. Frontiers in Oncology. 2022; doi:10.3389/fonc.2022.885504. Medical review (expert opinion). Mayo Clinic. June 13, 2025. Peritoneal carcinomatosis症状与病因诊断与治疗医生与科室在 Mayo Clinic 治疗 Advertisement 妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。 广告与赞助政策 政策 机会 广告选择 妙佑医疗国际出版社 浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。 新资讯:妙佑医疗国际睡眠改善指南 收听健康问题播客 妙佑医疗国际:关于失禁 糖尿病基本信息 妙佑医疗国际饮食方案评估 — 免费 妙佑医疗国际健康通讯 — 免费读物 CON-20583553 疾病与状况 Peritoneal carcinomatosis